| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer : correlation with traditional prognostic factors
Authors:ID Lampelj, Maja (Author)
ID Arko, Darja (Author)
ID Čas-Sikošek, Nina (Author)
ID Kavalar, Rajko (Author)
ID Ravnik, Maja (Author)
ID Jezeršek Novaković, Barbara (Author)
ID Dobnik, Sarah (Author)
ID Fokter Dovnik, Nina (Author)
ID Takač, Iztok (Author)
Files:.pdf Radiology_and_Oncology_2015_Lampelj_et_al._Urokinase_plasminogen_activator_(uPA)_and_plasminogen_activator_inhibitor_type-1_(PAI-1)_in_b.pdf (597,75 KB)
MD5: A11826B75B1BE7C69B91DD7D6368EE98
 
URL http://www.degruyter.com/view/j/raon.2015.49.issue-4/raon-2014-0049/raon-2014-0049.xml
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Background: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the correlation between traditional prognostic factors and uPA and PAI-1 expression in primary tumour of breast cancer patients. Patients and methods: 606 primary breast cancer patients were enrolled in the prospective study in the Department of gynaecological oncology and breast oncology at the University Medical Centre Maribor between the years 2004 and 2010. We evaluated the traditional prognostic factors (age, menopausal status, tumour size, pathohistological type, histologic grade, lymph node status, lymphovascular invasion and hormone receptor status), together with uPA and PAI-1. We used Spearman%s rank correlation, Mann Whitney U test and X2 test for statistical analysis. Results: Our findings indicate a positive correlation between uPA and tumour size (p < 0.001), grade (p < 0.001), histological type (p < 0.001), lymphovascular invasion (p = 0.01) and a negative correlation between uPA and hormone receptor status (p < 0.001). They also indicate a positive correlation between PAI-1 and tumour size (p = 0.004), grade (p < 0.001), pathohistological type (p < 0.001) and negative correlation between PAI-1 and hormone receptor status (p = 0.002). Conclusions: Our study showed a relationship between uPA and PAI-1 and traditional prognostic factors. Their role as prognostic and predictive factors remains to be further evaluated.
Keywords:urokinase plasminogen activator, plasminogen activator inhibitor, breast cancer
Publication status:Published
Publication version:Version of Record
Year of publishing:2015
Number of pages:str. 357-364
Numbering:Letn. 49, št. 4
PID:20.500.12556/DKUM-59286 New window
ISSN:1318-2099
UDC:618.1-006
ISSN on article:1318-2099
COBISS.SI-ID:1979259 New window
DOI:10.2478/raon-2014-0049 New window
NUK URN:URN:SI:UM:DK:NWN4HSHW
Publication date in DKUM:05.04.2017
Views:1414
Downloads:175
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Radiology and oncology
Shortened title:Radiol. oncol.
Publisher:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 New window

Document is financed by a project

Funder:ARRS - Slovenian Research Agency
Project number:P3-0321
Name:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri raku dojk in drugih rakih

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:11.05.2016

Secondary language

Language:Slovenian
Keywords:rak dojke, urokinaza, aktivator plazminogena, plazminogen


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica